Insulin maker Novo Nordisk A/S (NVO) said its net profit for 2014 increased by 5% to 26.5 billion Danish kroner, with annual earnings per share up 8% to 10.07 kroner.
Operating profit for the year increased by 13% in local currencies and by 10% in Danish kroner to 34.5 billion kronor.
Sales increased by 8% in local currencies and by 6% in Danish kroner to 88.8 billion.
For 2015, sales growth is expected to be 6-9% and operating profit growth is expected at around 10%, both measured in local currencies.
For comments and feedback contact: editorial@rttnews.com
Business News